FULC EPS Estimates
Fulcrum Therapeutics, Inc.
$3.69
+$0.02(+0.54%)
50
Overall
60
Value
60
Tech
31
Quality
Market Cap
$280.32M
Volume
450.57K
52W Range
$2.83 - $15.74
Target Price
$6.40
FULC EPS estimates: the consensus estimate for Fulcrum Therapeutics, Inc.'s current fiscal year is -$0.60 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
FULC EPS Estimates
- EPS estimate, current quarter
- $-0.10
- EPS estimate, next quarter
- $-0.08
- EPS estimate, current year
- $-0.60
- EPS estimate, next year
- $-0.12
- EPS growth, 3-year
- +21.51%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.18 |
| 2024 | $-0.16 |
| 2023 | $-1.59 |
| 2022 | $-2.44 |
| 2021 | $-2.29 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FULC | $3.69 | +0.5% | 450.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Fulcrum Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW